Skip to content

ZYNERBA PHARMACEUTICALS, INC.: 10-K filed 2022-03-01

What ZYNERBA PHARMACEUTICALS, INC. reported in its annual report filed 2022-03-01 (fiscal FY 2021): 40 published measures, 107 facts as tagged in accession 0001558370-22-002451.

This filing

Form
10-K (annual report)
Filed
2022-03-01
Fiscal period
fiscal FY 2021
Accession
0001558370-22-002451 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ZYNERBA PHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2021-12-3181,171,507USD
At 2020-12-3174,056,776USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2021-12-3110,258,173USD
At 2020-12-3113,913,248USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2021-12-3170,913,334USD
At 2020-12-3160,143,528USD
At 2019-12-3175,596,743USD
At 2018-12-3157,601,661USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2021-12-3167,808,000USD
At 2020-12-3159,157,187USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-37,309,024USD365
2020-01-01 to 2020-12-31-51,336,831USD366
2019-01-01 to 2019-12-31-32,943,583USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-33,457,476USD365
2020-01-01 to 2020-12-31-41,314,040USD366
2019-01-01 to 2019-12-31-34,817,976USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2021-01-01 to 2021-12-3147,570USD365
2020-01-01 to 2020-12-31445,314USD366
2019-01-01 to 2019-12-31129,390USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2021-01-01 to 2021-12-3142,155,859USD365
2020-01-01 to 2020-12-3130,853,299USD366
2019-01-01 to 2019-12-3145,246,835USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-47,570USD365
2020-01-01 to 2020-12-31-445,314USD366
2019-01-01 to 2019-12-31-129,390USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2021-12-31-239,481,479USD
At 2020-12-31-202,172,455USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2021-01-01 to 2021-12-3139,259,495shares365
2020-01-01 to 2020-12-3127,022,931shares366
2019-01-01 to 2019-12-3122,000,203shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2021-01-01 to 2021-12-3139,259,495shares365
2020-01-01 to 2020-12-3127,022,931shares366
2019-01-01 to 2019-12-3122,000,203shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-0.95USD/shares365
2020-01-01 to 2020-12-31-1.9USD/shares366
2019-01-01 to 2019-12-31-1.5USD/shares365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-0.95USD/shares365
2020-01-01 to 2020-12-31-1.9USD/shares366
2019-01-01 to 2019-12-31-1.5USD/shares365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2021-12-31385,833USD
At 2020-12-31585,403USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2021-01-01 to 2021-12-315,810,580USD365
2020-01-01 to 2020-12-315,177,527USD366
2019-01-01 to 2019-12-315,561,895USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-36,770,390USD365
2020-01-01 to 2020-12-31-52,062,542USD366
2019-01-01 to 2019-12-31-34,319,810USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2021-12-3180,219,860USD
At 2020-12-3173,366,174USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2021-12-319,904,479USD
At 2020-12-3113,913,248USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2021-12-311,798,813USD
At 2020-12-312,522,716USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2021-01-01 to 2021-12-3136,770,390USD365
2020-01-01 to 2020-12-3152,062,542USD366
2019-01-01 to 2019-12-3134,319,810USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2021-01-01 to 2021-12-3121,424,489USD365
2020-01-01 to 2020-12-3135,654,994USD366
2019-01-01 to 2019-12-3120,384,049USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2021-12-3141,217,537shares
At 2020-12-3129,975,264shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2021-12-3167,808,000USD
At 2020-12-3159,157,187USD
At 2019-12-3170,063,242USD
At 2018-12-3159,763,773USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2021-12-31310,353,595USD
At 2020-12-31262,286,008USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2021-12-31565,814USD
At 2021-03-01752,391USD
At 2020-12-31105,199USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2021-12-31562,762USD
At 2021-03-01755,085USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2021-12-311,230,441USD
At 2020-12-311,182,871USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2021-12-31844,608USD
At 2020-12-31597,468USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2021-12-317,896,598USD
At 2020-12-3111,280,843USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2021-12-312,831,392USD
At 2020-12-315,166,401USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-37,309,024USD365
2020-01-01 to 2020-12-31-51,336,831USD366
2019-01-01 to 2019-12-31-32,943,583USD365

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-37,309,024USD365
2020-01-01 to 2020-12-31-51,336,831USD366
2019-01-01 to 2019-12-31-32,943,583USD365

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-37,309,024USD365
2020-01-01 to 2020-12-31-51,336,831USD366
2019-01-01 to 2019-12-31-32,943,583USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2021-01-01 to 2021-12-3115,345,901USD365
2020-01-01 to 2020-12-3116,407,548USD366
2019-01-01 to 2019-12-3113,935,761USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2021-01-01 to 2021-12-31247,140USD365
2020-01-01 to 2020-12-31207,035USD366
2019-01-01 to 2019-12-31133,879USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-538,634USD365
2020-01-01 to 2020-12-31725,711USD366
2019-01-01 to 2019-12-311,376,227USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2021-01-01 to 2021-12-3143,193,660USD365
2020-01-01 to 2020-12-3131,707,228USD366
2019-01-01 to 2019-12-3146,907,032USD365

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2021-01-01 to 2021-12-31310,448USD365
2020-01-01 to 2020-12-31318,561USD366
2019-01-01 to 2019-12-31305,477USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-723,903USD365
2020-01-01 to 2020-12-31-2,145,165USD366
2019-01-01 to 2019-12-31209,613USD365

Inspect the source

Entity
ZYNERBA PHARMACEUTICALS, INC. / CIK 0001621443
Captured
SEC response SHA-256
eb291da6063ca15bb79701a29894e4fddd9d66bcb1e18e0733be9f2efb07eaa3

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001621443.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))